Search

Your search keyword '"Serpi R"' showing total 81 results

Search Constraints

Start Over You searched for: Author "Serpi R" Remove constraint Author: "Serpi R"
81 results on '"Serpi R"'

Search Results

1. New insights into the genetic etiology of Alzheimer's disease and related dementias

2. Contribution of HIF-P4H isoenzyme inhibition to metabolism indicates major beneficial effects being conveyed by HIF-P4H-2 antagonism

3. Activation of the hypoxia response pathway protects against age-induced cardiac hypertrophy

4. Genetic ablation of P4H-TM (transmembrane prolyl 4-hydroxylase) reduces atherosclerotic plaques in mice

5. Systematic evaluation of the association between hemoglobin levels and metabolic profile implicates beneficial effects of hypoxia

6. Systemic long‐term inactivation of hypoxia‐inducible factor prolyl 4‐hydroxylase 2 ameliorates aging‐induced changes in mice without affecting their life span

7. Systemic blockade of ACVR2B ligands attenuates muscle wasting in ischemic heart failure without compromising cardiac function

8. Phosphorylation of GATA4 at serine 105 is required for left ventricular remodelling process in angiotensin II‐induced hypertension in rats

9. HIF-P4H-2 inhibition enhances intestinal fructose metabolism and induces thermogenesis protecting against NAFLD

10. Systemic inactivation of hypoxia-inducible factor prolyl 4-hydroxylase 2 in mice protects from alcohol-induced fatty liver disease

11. SDF1 gradient associates with the distribution of c-Kit+ cardiac cells in the heart

12. Hypoxia causes reductions in birth weight by altering maternal glucose and lipid metabolism

13. Cardiac actions of a small molecule inhibitor targeting GATA4–NKX2-5 interaction

14. Discovery of small molecules targeting the synergy of cardiac transcription factors GATA4 and NKX2-5

15. Notch downregulation and extramedullary erythrocytosis in hypoxia-inducible factor prolyl 4-hydroxylase 2-deficient mice

16. Mechanism of benzo(a)pyrene-induced accumulation of p53 tumour suppressor protein in mouse

21. Thapsigargin has similar effect on p53 protein response to benzo[a]pyrene-DNA adducts as TPA in mouse skin

22. Inbred wild type mouse strains have distinct spontaneous morphological phenotypes

23. Reverse Transcriptase-Mediated Tropism Switching in Bordetella Bacteriophage.

24. Metabolic characteristics of transmembrane prolyl 4-hydroxylase (P4H-TM) deficient mice.

25. TWINGEN: protocol for an observational clinical biobank recall and biomarker cohort study to identify Finnish individuals with high risk of Alzheimer's disease.

26. TWINGEN - protocol for an observational clinical biobank recall and biomarker study to identify individuals with high risk of Alzheimer's disease.

27. Author Correction: FinnGen provides genetic insights from a well-phenotyped isolated population.

28. FinnGen provides genetic insights from a well-phenotyped isolated population.

29. Contribution of HIF-P4H isoenzyme inhibition to metabolism indicates major beneficial effects being conveyed by HIF-P4H-2 antagonism.

30. Activation of the hypoxia response protects mice from amyloid-β accumulation.

31. Activation of the hypoxia response pathway protects against age-induced cardiac hypertrophy.

32. Systematic evaluation of the association between hemoglobin levels and metabolic profile implicates beneficial effects of hypoxia.

33. Genetic Ablation of Transmembrane Prolyl 4-Hydroxylase Reduces Atherosclerotic Plaques in Mice.

34. Phosphorylation of GATA4 at serine 105 is required for left ventricular remodelling process in angiotensin II-induced hypertension in rats.

35. Systemic blockade of ACVR2B ligands attenuates muscle wasting in ischemic heart failure without compromising cardiac function.

36. HIF-P4H-2 inhibition enhances intestinal fructose metabolism and induces thermogenesis protecting against NAFLD.

37. Systemic long-term inactivation of hypoxia-inducible factor prolyl 4-hydroxylase 2 ameliorates aging-induced changes in mice without affecting their life span.

39. Systemic inactivation of hypoxia-inducible factor prolyl 4-hydroxylase 2 in mice protects from alcohol-induced fatty liver disease.

40. Hypoxia causes reductions in birth weight by altering maternal glucose and lipid metabolism.

41. Cardiac Actions of a Small Molecule Inhibitor Targeting GATA4-NKX2-5 Interaction.

42. SDF1 gradient associates with the distribution of c-Kit+ cardiac cells in the heart.

43. Discovery of Small Molecules Targeting the Synergy of Cardiac Transcription Factors GATA4 and NKX2-5.

44. Notch Downregulation and Extramedullary Erythrocytosis in Hypoxia-Inducible Factor Prolyl 4-Hydroxylase 2-Deficient Mice.

45. Hypoxia-inducible factor prolyl 4-hydroxylase inhibition in cardiometabolic diseases.

46. Iron-labeled adipose stem cells and neovascularization in rabbit calvarial critical-sized defects.

47. Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis.

48. HIF-P4H-2 deficiency protects against skeletal muscle ischemia-reperfusion injury.

49. The Early-Onset Myocardial Infarction Associated PHACTR1 Gene Regulates Skeletal and Cardiac Alpha-Actin Gene Expression.

50. WDR12, a Member of Nucleolar PeBoW-Complex, Is Up-Regulated in Failing Hearts and Causes Deterioration of Cardiac Function.

Catalog

Books, media, physical & digital resources